55111-625 : Zafirlukast 10 mg Oral Tablet


NDC: 55111-625
Labeler: Dr. Reddys Laboratories Limited
Product Type: Human Prescription Drug
Drug Name:  Zafirlukast
Dosage Form: Oral Tablet, Film Coated
Application #: ANDA090372
Rev. Date: 


Appearance:


Markings: R;625
Shapes:  Round
Colors:  Pink
Size (mm): 6
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

R 625: (55111-625) Zafirlukast 10 mg Oral Tablet by Dr. Reddys Laboratories Limited
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 55111-625-01: 100 TABLET, FILM COATED IN 1 BOTTLE (55111‑625‑01)
  • 55111-625-05: 500 TABLET, FILM COATED IN 1 BOTTLE (55111‑625‑05)
  • 55111-625-30: 30 TABLET, FILM COATED IN 1 BOTTLE (55111‑625‑30)
  • 55111-625-60: 60 TABLET, FILM COATED IN 1 BOTTLE (55111‑625‑60)
  • 55111-625-78: 10 BLISTER PACK IN 1 CARTON (55111‑625‑78) > 10 TABLET, FILM COATED IN 1 BLISTER PACK (55111‑625‑79)

Active Ingredients:

  • Zafirlukast

Dosage Strength:

  • 10 mg

Inactive Ingredients:

  • Hydroxypropyl Cellulose
  • Hypromellose 2910 (5 Mpa.s)
  • Lactose Monohydrate
  • Magnesium Stearate
  • Cellulose, Microcrystalline
  • Polyethylene Glycol 400
  • Sodium Starch Glycolate Type a Potato
  • Titanium Dioxide

Pharmaceutical Classes:

  • Leukotriene Receptor Antagonists [MoA]
  • Cytochrome P450 2C9 Inhibitors [MoA]
  • Leukotriene Receptor Antagonist [EPC]

Related Products:

Based on records with the same trade name.
  • 55111-626 Zafirlukast 20 mg Oral Tablet by Dr. Reddys Laboratories Limited
  • 0310-0411 Zafirlukast 10 mg Oral Tablet by Astrazeneca Pharmaceuticals Lp
  • 0310-0412 Zafirlukast 20 mg Oral Tablet by Astrazeneca Pharmaceuticals Lp
  • 0904-6646 Zafirlukast 20 mg Oral Tablet, Coated by Major Pharmaceuticals
  • 16571-654 Zafirlukast 10 mg Oral Tablet by Rising Pharmaceuticals, Inc.
  • 16571-655 Zafirlukast 20 mg Oral Tablet by Rising Pharmaceuticals, Inc.
  • 31722-007 Zafirlukast 10 mg Oral Tablet, Film Coated by Camber Pharmaceuticals, Inc.
  • 31722-008 Zafirlukast 20 mg Oral Tablet, Film Coated by Camber Pharmaceuticals, Inc.
  • 42291-970 Zafirlukast 10 mg Oral Tablet, Coated by Avkare
  • 42291-971 Zafirlukast 20 mg Oral Tablet, Coated by Avkare
  • 49884-303 Zafirlukast 10 mg Oral Tablet by Par Pharmaceutical Inc.
  • 49884-304 Zafirlukast 20 mg Oral Tablet by Par Pharmaceutical Inc.
  • 49884-549 Zafirlukast 10 mg Oral Tablet, Coated by Par Pharmaceutical Inc.
  • 49884-554 Zafirlukast 20 mg Oral Tablet, Coated by Par Pharmaceutical Inc.
  • 50268-805 Zafirlukast 20 mg Oral Tablet, Film Coated by Avpak
  • 59651-291 Zafirlukast 10 mg Oral Tablet, Film Coated by Aurobindo Pharma Limited
  • 59651-292 Zafirlukast 20 mg Oral Tablet, Film Coated by Aurobindo Pharma Limited
  • 63629-2102 Zafirlukast 10 mg Oral Tablet, Coated by Bryant Ranch Prepack
  • 64380-187 Zafirlukast 10 mg Oral Tablet, Coated by Strides Pharma Science Limited
  • 64380-188 Zafirlukast 20 mg Oral Tablet, Coated by Strides Pharma Science Limited
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 55111-625 QR Code

< Prev: 55111-624Next: 55111-626 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.